- Travis Leonardi
- President
- Chad Mccall
- Director
In addition to the information collected by our system, Sentry also collects information from visitors who voluntarily communicate with us on this Website. Visitors to our Website may provide their consent to be added to our electronic newsletter by providing a name and email address for this purpose. You may opt out of future receipt of the electronic newsletter at any time through a link at the bottom of the electronic newsletter.
“At its core, Sentry is a data company—and we’ve always placed a high value on the security of our customers’ data and the high availability of our processing platform,” says Travis Leonardi, CEO and founder of Sentry Data Systems. “We process data for an average of 3.2 million drug dispensations a day, so we need to be fast and we need to be secure.
Our facility was one of the participants in the initial 2012 audits of the HRSA/OPA 340B Program. We were confident in our program integrity, but facing a HRSA/OPA review of our program was an unknown and daunting task. Our apprehension was calmed by our strong, firm relationship with Sentry Data Systems. They provided assistance in data gathering, answering questions of detailed data system operations, providing two staff members on-site during the HRSA/OPA auditor’s visit and system review follow-up for optimum program integrity.